Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

BioCrude Technologies USA Q3 2026 Results: Net Loss of $20.5K, Loss Narrows

BioCrude Technologies USA, Inc. reported zero revenue for the nine months ended September 30, 2026, with a net loss of $83,366. The company continues to operate as a going concern with an accumulated deficit of $9,764,258 and total assets of only $5,705, funding operations primarily through private placements and related party advances.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Net income-0.0-0.0
EPS (diluted, $ a share)$-0.00$-0.00

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Source

10-Q filed with the SEC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

BioCrude Technologies USA, Inc.: key numbers

Shares outstanding
50.88MLatest SEC cover page
Sector
Energy & Transportation
Industry
Refuse SystemsSIC 4953

Today's reference numbers, updated daily. Not a valuation or a recommendation.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.